Chart Industries to Announce Fourth Quarter and Full Year 2024 Results on February 28
Chart Industries, Inc. (NYSE: GTLS) (“Chart”), a global leader in energy and industrial gas solutions, has scheduled a conference call for Friday, February 28, 2025 at 8:30 a.m. ET to discuss its ...
TMCnet3h
X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor for the Treatment of WHIM Syndrome
If approved by the EMA, mavorixafor would be the first drug indicated for patients with WHIM syndrome in Europe, a population estimated to be approximately 1,000 people. Earlier this month X4 ...